4/A
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-099014
Chief Operating Officer gave up 3,048 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beetham Thomas W. Chief Operating Officer | 2026-03-03 | Shares withheld for taxes | −3,048 | $30.19 | $92,019 | 13,361 | D |
Loading xslF345X05/ownership.xml…